Please enjoy this post from the Clinical Correlations archives first posted March 26, 2009
By: Melissa Price, MD
Faculty Peer Reviewed
A 42 year-old male phlebotomist with a history of anxiety …
Category: Systems
Clinical Correlations
Early Repolarization: Not as Innocent as Once Thought!
January 5, 2011
By Rachel Bond, MD PGY-2
Faculty Peer Reviewed
For many years, the electrocardiogram, a seemingly simple transthoracic interpretation of the electrical activity of the heart captured and externally recorded, has fascinated healthcare professionals. …
Meeting Perspectives: The 2010 Infectious Disease Society of America (IDSA) Meeting
December 22, 2010Neal H. Steigbigel, M.D.
The recent IDSA meeting reviewed many important and interesting findings. Topics spanned a wide array of subjects, many of which are of importance and interest to all physicians.  These …
Is a Low Vitamin D Level a Risk Factor for Colon Cancer?
December 16, 2010
By Nelson Sanchez, MD and Fritz Francois, MD, MS
Faculty Peer Reviewed
Case: A 45-year-old woman presents to your office for an annual check-up. She states that her grandmother …
The Polymyxins: Why am I using them all the time, and what are they?
December 8, 2010
By Jon-Emile S Kenny
Faculty Peer Reviewed
A 65-year-old female with locally advanced rectal cancer is admitted to the ICU, hypotensive and febrile. Her PICC line is removed and …
Branched Chain Amino Acid Supplementation for Patients with Cirrhosis
December 3, 2010
By Nicole Leigh Aaronson,MD,  Loren Wissner Greene, MD, and Denise Pate, MD
Faculty Peer Reviewed
Introduction:
Whereas there are specially designed diets for patients with hypertension, diabetes, and …
Kayexalate: What is it and does it work?
December 1, 2010
By Todd Cutler, MD
Faculty Peer Reviewed
A 62-year-old male is hospitalized with an acute congestive heart failure exacerbation. On hospital day three, the patient’s symptoms have significantly …
Proton Pump Inhibitors 2.0
November 26, 2010
By Mary C. Whitman, MD
Faculty Peer Reviewed
Proton pump inhibitors (PPIs) are generally considered “safe†medications[1] and are prescribed to over 100 million patients per year for a variety of indications, often …